Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

Mark Robert Keaton

Mark Robert Keaton publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research and Breast Cancer Treatment Studies.

OpenAlex
World rank
#3,025,664
of 7,710,434 ranked researchers
Rank in United States
#867,465
of 1,627,098
Works
32
Citations
991
Citations per work
31.0
h-index
10
i10-index 10Top 59% in Oncology

What does Mark Robert Keaton research?

Mark Robert Keaton's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (16%).

Life Sciences16%Health Sciences76%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2475.7%
    1. Biochemistry, Genetics and Molecular Biology516.1%
  1. Everything else38.2%
  1. 1Oncology55% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Cancer Research13% of their works
  4. 4Cardiology and Cardiovascular Medicine3% of their works
  5. 5Cell Biology2% of their works
  6. 6Molecular Biology2% of their works

Research topics

Which keywords describe Mark Robert Keaton's research?

The keywords of their largest research topics: Chemotherapy, Metastatic Breast Cancer, Breast Cancer, Molecular Subtypes, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Trastuzumab and EGFR.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Chemotherapy214 topics
  2. Metastatic Breast Cancer182 topics
  3. Breast Cancer152 topics
  4. Molecular Subtypes142 topics
  5. Chemotherapy-Induced Peripheral Neuropathy131 topic
  6. Taxanes131 topic
  7. Trastuzumab122 topics
  8. EGFR101 topic
  9. HER2101 topic
  10. Breast Tumours81 topic
  11. Clinical Trials82 topics
  12. Gene Expression81 topic
  13. Targeted Therapy82 topics
  14. Cetuximab61 topic
  15. KRAS Mutations61 topic
  16. ALK Inhibitors51 topic
  17. CDK4/6 Inhibitors51 topic
  18. EGFR Mutations51 topic
  19. Palbociclib51 topic
  20. Genomic Profiles31 topic
  21. Small-Cell Lung Cancer31 topic
  22. Anthracyclines21 topic
  23. Doxorubicin21 topic

Where does Mark Robert Keaton work?

Mark Robert Keaton's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Mark Robert Keaton have?

OpenAlex counts 32 works and 991 citations for Mark Robert Keaton, an h-index of 10, ranking #3,025,664 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark Robert Keaton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.